Zhengping Zhao
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Pan-cancer analysis and experimental verification of its roles and clinical significance of SLC2A3 in kidney renal clear cell carcinoma.
Journal: Frontiers in immunology
Published: August 28, 2025
Application of serum miRNA panel in bladder cancer detection.
Journal: Translational andrology and urology
Published: August 11, 2025
Evaluation of the diagnostic performance of YiDiXie™ tests in urothelial carcinoma.
Journal: European journal of medical research
Published: June 15, 2025
Testing the accuracy of a four serum microRNA panel for the detection of primary bladder cancer: a discovery and validation study.
Journal: Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals
Published: May 20, 2024
A three miRNAs panel in paraffin tissue serves as tool for predicting prognosis of renal cell carcinoma.
Journal: Frontiers in oncology
Published: February 26, 2024
Regulation of Interferon-β-Modified Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Proliferation and Apoptosis of Prostate Cancer Cells.
Journal: Organogenesis
Published: November 30, 2023
A serum panel of three microRNAs may serve as possible biomarkers for kidney renal clear cell carcinoma.
Journal: Cancer cell international
Published: July 22, 2023
Identification of PDCL2 as a candidate marker in Sertoli cell-only syndrome by chromatin immunoprecipitation-sequencing and bioinformatics analysis.
Journal: Translational andrology and urology
Published: May 24, 2023
A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis.
Journal: Frontiers in oncology
Published: October 21, 2022
GLIDR promotes the aggressiveness progression of prostate cancer cells by sponging miR-128-3p.
Journal: Pathology, research and practice
Published: September 26, 2022
Bladder cancer diagnosis with a four-miRNA panel in serum.
Journal: Future oncology (London, England)
Published: September 01, 2022
A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma.
Journal: Frontiers in genetics
Published: March 16, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026